The AIM-HN Study: A pivotal study evaluating the efficacy of tipifarnib in patients with recurrent or metastatic head and neck squamous cell carcinoma with HRAS mutations Meeting Abstract
| Authors: | Haddad, R. I.; Adkins, D.; Licitra, L. F.; Bruce, J. Y.; Gillison, M. L.; Ahn, M. J.; Hsieh, C. Y.; Wang, H. M.; Psyrri, A.; Machiels, J. P. H.; Balsara, B.; Leoni, M.; Harrington, K. J.; Saba, N. F.; Ho, A. L. |
| Abstract Title: | The AIM-HN Study: A pivotal study evaluating the efficacy of tipifarnib in patients with recurrent or metastatic head and neck squamous cell carcinoma with HRAS mutations |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306346 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS6087 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS6087 -- Source: Wos |
